Table 4.

Clinical Characteristics of S. Suis Infected Patients for Mortality

Characteristics	Total	Died (n=16, 12.03%)		Survived (n=117, 87.97%)		OR	95% CI	p-value
n	%	n	%
Age (years) (mean±SD)	56.47± 13.68	58.25±15.61	NA	56.23±13.46	NA	1.01	0.97–1.05	0.578
Male sex	92 (69.17%)	11	68.75	81	69.23	0.98	0.32–3.02	0.969
GCS < 8	NA	9.92± 3.95	NA	13.06± 2.83	NA	9.42	2.08–42.55	0.006
SAPS II > 50	NA	46.56± 17.64	NA	24.34±10.87	NA	21.97	5.40–89.42	<0.001
Time to microbiological cure ≥ 6 days	NA	6.33± 3.44	NA	8.96± 14.39	NA	6.21	1.35–28.55	0.005
Underlying disease
VHD	44 (33.08%)	5	11.36	39	88.64	0.91	0.30–2.80	0.868
ALD	16 (12.03%)	5	31.25	11	68.75	4.38	1.29–14.93	0.026
DM	26 (19.55%)	4	15.38	22	84.62	1.43	0.42–4.89	0.568
Major clinical manifestations
Acute meningitis	50 (37.59%)	2	4	48	96	0.21	0.04–0.95	0.018
Septicemia	74 (55.64%)	12	16.22	62	83.78	2.66	0.81–8.73	0.088
Septic shock	20 (15.27%)	9	45.00	11	55.00	12.39	3.86–39.79	<0.001
IE	34 (25.56%)	3	8.82	31	91.18	0.64	0.17–2.40	0.493
Received dexamethasone	27 (20.30%)	1	3.740	26	96.30	0.23	0.03–1.85	0.096
Total bilirubin >2.5 mg/dL	1.78±3.33	4.90±8.19	NA	1.30±1.17	NA	3.90	1.33–11.41	0.013
Direct bilirubin >1.5mg/dL	0.89±2.01	2.74±4.89	NA	0.60±0.76	NA	5.30	1.77–15.88	0.002
WBC count (cells/cu.mm)	19,897±37,555	15,117± 8512.37	NA	20,574±39,981	NA	1.0	1.00–1.00	0.472
AST >300 U/L	100.31± 161.64	179.53±252.09	NA	88.18±140.98	NA	2.0	0.67–6.01	0.228
ALT >300 U/L	62.23± 66.93	84.33± 110	NA	58.84±57.78	NA	1.44	0.42–4.89	0.568
BUN >28 mg/dL	25.64± 22.71	38.25± 42.83	NA	23.86±17.83	NA	4.24	1.43–12.61	0.008
Creatinine > 1.8 mg/dL	1.80± 2.50	3.01± 4.97	NA	1.63± 1.90	NA	4.73	1.60–13.96	0.005
Bicarbonate < 18 mmol/L	21.44± 4.39	18.81± 5.86	NA	21.82±4.03	NA	4.91	1.60–15.04	0.007
Phosphorus > 4.5 mg/dL	3.75± 1.90	5.27± 3.00	NA	3.48± 1.50	NA	1.91	0.67–5.50	0.225
Albumin < 3.5 g/dL	3.12± 0.59	2.75± 0.53	NA	3.17± 0.58	NA	5.04	1.10–23.21	0.015
Globulin > 4 g/dL	3.53± 0.80	3.99± 0.87	NA	3.46± 0.76	NA	2.48	0.86–7.14	0.092